Search

everythinglearnresearchcommunity

for

Search:↓

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Allium ascalonicum L. extract may help improve insulin resistance.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Obese women with PCOS are more likely to have fatty liver disease.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Bald men may have higher heart disease risk.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Baldness may indicate higher heart disease risk in men.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

People with male pattern baldness are more likely to have metabolic syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

Hidden fungal infections might cause heart disease and clogged arteries.